Carolina Molecular
Morrisville, US · Founded 2025 · Delaware corporation
Carolina Molecular is a molecular testing and analysis services provider offering sample extraction, expression profiling, and genomic analysis using platforms like Illumina sequencing, GeoMx spatial profiling, and Luminex. It serves CROs/CDMOs, cell and gene therapy innovators, technology providers, and research institutions for clinical diagnostics, discovery research, and product development.
BiotechHealthtechMedical Devices
Founders & leadership
TC
Trent CarrierExecutive
Board
JC
John CorlissBoard director
MW
Max WeisBoard director
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2025
▶$1.1MraisedNov 2025 · 8 investors · BiotechnologyRule 506(b)
▶$1.1MraisedNov 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Trent CarrierExecutive Officer, Director
- John CorlissDirector
- Max WeisDirector
- Offering amount
- $1.7M
- Amount sold
- $1.1M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp14 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Molecular Devices10 shared keywordsMolecular Devices develops laboratory instruments and automated workflows for life science research, including SpectraMax microplate readers, high-content screening and imaging systems, colony-picking devices, and 3D organoid and cell culture solutions. It serves researchers in drug discovery, cell line development, and screening, supported by AI-enabled analysis software and GxP compliance tools.
Genomeweb8 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Companies competing with Carolina Molecular for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Carolina Molecular do?
- Carolina Molecular is a molecular testing and analysis services provider offering sample extraction, expression profiling, and genomic analysis using platforms like Illumina sequencing, GeoMx spatial profiling, and Luminex. It serves CROs/CDMOs, cell and gene therapy innovators, technology providers, and research institutions for clinical diagnostics, discovery research, and product development.
- How much funding has Carolina Molecular raised?
- Carolina Molecular has disclosed $1.1M raised across 1 round.
- Where is Carolina Molecular headquartered?
- Carolina Molecular is headquartered in Morrisville, US.